Isofol ingår licensavtal med Paladin Labs Inc. för att kommersialisera arfolitixorin i Kanada
GÖTEBORG, Sverige, 2 november, 2020 – Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), meddelar idag att…
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.